test

BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study

Conditions

Lung | Non Small Cell Lung Cancer

What is the purpose of this trial?

PURPOSE OF STUDY Different people have different biomarkers (chemical "markers" in the blood that may be related to your reaction to study drugs). If researchers know about your biomarkers before you receive treatment, they may be able to prescribe a treatment that is better suited to your body's specific needs. The goal of this clinical research study is to learn if a drug or drug combinations based on your biomarkers can help to control NSCLC. The safety of these drug combinations will also be studied.


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
University of Texas M.D. Anderson Cancer Center
Dates:
09/14/2012
Last Updated:
Study HIC#:
1108008990